Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

Abstract Background Recurrence and metastases are still frequent outcomes after initial tumour control in women diagnosed with breast cancer. Although therapies are selected based on tumour characteristics measured at baseline, prognostic biomarkers can identify those at risk of poor outcomes. Circu...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Alexandre Prieur, Andrew Harper, Momtafin Khan, Bérengère Vire, Dominique Joubert, Léa Payen, Karen Kopciuk
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-04-01
Saila:	BMC Cancer
Gaiak:	Breast cancer Circulating progastrin hPG80 Prognostic biomarker Recurrence Survival
Sarrera elektronikoa:	https://doi.org/10.1186/s12885-023-10729-1
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!